Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clarus Corporation - Common Stock (NQ: CLAR )

4.780 -0.070 (-1.44%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarus Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
Clarus Sets Second Quarter 2023 Conference Call for Monday, August 7, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
Via Benzinga
Expert Ratings for Clarus
Via Benzinga
What 4 Analyst Ratings Have To Say About Clarus
Via Benzinga
Clarus Announces June Investor Conference Schedule
From Clarus Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Via Benzinga
Clarus: Dividend Insights
Via Benzinga
Clarus Reports First Quarter 2023 Results
From Clarus Corporation
Via GlobeNewswire
Clarus Earnings Preview
Via Benzinga
Clarus's Return On Capital Employed Insights
Via Benzinga
Friday Is Your Last Chance To Buy Clarus Before The Dividend Payout
Via Benzinga
Earnings Preview For Clarus
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Clarus's Return on Invested Capital Overview
Via Benzinga
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
Clarus Sets First Quarter 2023 Conference Call for Monday, May 1, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Clarus Announces March Investor Conference Schedule
From Clarus Corporation
Via GlobeNewswire
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Via Benzinga
Clarus Reports Fourth Quarter and Full Year 2022 Results
From Clarus Corporation
Via GlobeNewswire
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
Clarus Sets Fourth Quarter and Full Year 2022 Conference Call for Monday, February 27, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
Clarus’ Black Diamond Equipment Appoints Neil Fiske as Brand President
From Clarus Corporation
Via GlobeNewswire
10 Consumer Discretionary Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
Via Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.